AL
ABEV icon

Aspiriant LLC’s Ambev ABEV Stock Holding History

Aspiriant LLC’s Portfolio ABEV Stock Details ABEV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$78.5K Hold
25,000
– – ﹤0.01% 398
2026
Q1 		$73K Sell
25,000
-148
-0.6% -$423 ﹤0.01% 337
2025
Q4 		$62.1K Buy
25,148
+148
+0.6% +$352 ﹤0.01% 319
2025
Q3 		$55.8K Sell
25,000
-1,603
-6% -$3.67K ﹤0.01% 297
2025
Q2 		$64.1K Buy
26,603
+101
+0.4% +$246 ﹤0.01% 309
2025
Q1 		$61.8K Sell
26,502
-7,133
-21% -$14.3K ﹤0.01% 288
2024
Q4 		$62.2K Buy
33,635
+8,547
+34% +$18.9K ﹤0.01% 288
2024
Q3 		$61.2K Buy
+25,088
New +$56.3K ﹤0.01% 290

Other funds holding ABEV

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SCP
Seafarer Capital Partners Larkspur, California $434M AUM 22.8% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Aspiriant LLC's ABEV Position: Q2 2026 in Review

Aspiriant LLC held its Ambev (ABEV) position steady in Q2 2026 at 25,000 shares worth $78.5K. The position accounts for ﹤0.01% of the portfolio, ranked #398.

Aspiriant LLC first reported a position in ABEV in Q3 2024 and has held it in 8 quarters since. 404 funds tracked by Wall St. Rank hold ABEV as of Q2 2026.

  • Aspiriant LLC held 25,000 shares of Ambev worth $78.5K as of Q2 2026.
  • Aspiriant LLC left its Ambev share count unchanged in Q2 2026.
  • Ambev made up ﹤0.01% of Aspiriant LLC's portfolio in Q2 2026, its #398 holding.
  • Aspiriant LLC first reported a position in Ambev in Q3 2024 and has held it in 8 quarters since.
  • 404 funds tracked by Wall St. Rank held Ambev as of Q2 2026.

Based on Aspiriant LLC's 13F filing for Q2 2026, filed 20 Jul 2026.